fda_approval · anda · info
ORIENT PHARMA — ANDA approval: TOFACITINIB CITRATE (unspecified)
- Event date
- 2026-06-09 00:00:00Z
- Observed
- 2026-07-09 22:53:28Z
- Source ID
- ANDA219830-1
- Payload hash
- 5b29d486583d1ca8fb2b9ca4…
Summary
ORIENT PHARMA received ANDA approval for TOFACITINIB CITRATE (unspecified) on 2026-06-09. Dosage form: TABLET, EXTENDED RELEASE. Application #: ANDA219830.
Entities
Informational only. Not legal, financial, or medical advice.